| Literature DB >> 29117372 |
Xu Meng1, Feifei Zhu1, Keping Chen1.
Abstract
As an important economic insect, silkworm Bombyx mori (L.) (Lepidoptera: Bombycidae) has numerous advantages in life science, such as low breeding cost, large progeny size, short generation time, and clear genetic background. Additionally, there are rich genetic resources associated with silkworms. The completion of the silkworm genome has further accelerated it to be a modern model organism in life science. Genomic studies showed that some silkworm genes are highly homologous to certain genes related to human hereditary disease and, therefore, are a candidate model for studying human disease. In this article, we provided a review of silkworm as an important model in various research areas, including human disease, screening of antimicrobial agents, environmental safety monitoring, and antitumor studies. In addition, the application potentiality of silkworm model in life sciences was discussed.Entities:
Keywords: antimicrobial drug; disease model; drug screening; model organism; silkworm
Mesh:
Year: 2017 PMID: 29117372 PMCID: PMC5633739 DOI: 10.1093/jisesa/iex064
Source DB: PubMed Journal: J Insect Sci ISSN: 1536-2442 Impact factor: 1.857
Fig. 1.Generation cycle pattern of the silkworm (Bombyx mori).
Silkworm models in life science
| Silkworm models | Test systems | Using of test systems | References |
|---|---|---|---|
| Disease silkworm models | Bacterial infection model |
| Hamamoto et al. (2004), Fujiyuki et al. (2012), Miyazaki et al. (2012) |
| Fungi infection model |
| Matsumoto et al. (2012), Ueno et al. (2011) | |
| Virus infection model | Human herpesvirus or Cytomegalovirus | Wang and Schweizer (2008) | |
| Diabetes (hyperglycemia) model | Type II diabetes | Matsumoto et al. (2014), Matsumoto et al. (2015) | |
| Antibiotic drug screening model | Nosokomycins | Kaito et al. (2002) | |
| Natural immunity stimulation test | Muscle contraction | β-Glucan, yeast β-1,6-glucan, green tea | Ishii et al. (2008), Fujiyuki et al. (2012) |
| Safety test | Pathogenicity test |
| Hamamoto et al. (2004), Fujiyuki et al. (2012), Miyazaki et al. (2012) |
| Toxicity test | Ethanol, | Hamamoto et al. (2008) | |
| Drug kinetics test | Gastrointestinal absorbability test | Chloramphenicol, tetracycline, vancomycin | Hamamoto et al. (2004) |
ED50 of antifungal agents in a silkworm model with Candida tropicalis or Candida albicans (Hamamoto et al. 2004, Ishii et al. 2017)
| Antifungal agent | True fungus | ED50 in silkworm (μg/g) | MIC μg/ml | ED50/MIC ratio in | |
|---|---|---|---|---|---|
| Silkworm | Mouse | ||||
| Amphotericin B |
| 1.8 | 3.2 | 0.6 | 0.2 |
|
| 4.1 | 1.6 | 2.6 | 1.3 | |
| Fluconazole |
| 1.8 | 1.6 | 1.1 | 7.4 |
|
| 1.8 | 0.4 | 4.5 | 8.6 | |
MIC (minimum inhibitory concentration).
The application of silkworm as human disease model
| Silkworm strain | Silkworm gene | Silkworm models | References |
|---|---|---|---|
| Albino ( |
| Human phenylketonuria | Blau and Bonafe (2001), Bonafé et al. (2001) |
| Lemon ( |
| Human sepiapterin reductase deficiency (SRD) model | Meng et al. (2009) |
| p-Translucent ( | PARK7/DJ-1 | Human Parkinson’s models | Chen et al. (2016) |
| d-Translucent ( |
| Hermansky–Pudlak syndrome | Wei (2006), Fujii et al. (2010) |
| Mottled translucent of var ( |
| ||
| Aojuku translucent ( |
|